The Company
A Global Specialist in Dermatology
Intendis is a specialized pharmaceutical company focused on the Dermatologicals category. Headquartered in Berlin, Germany the company was founded in 2005 as a subsidiary of Schering AG. Intendis has a successful track record of providing prescription drug products for the treatment of severe skin diseases and was a pioneer in the development of locally applicable corticosteroid treatments.
Today, Intendis is part of Bayer HealthCare with commercial operations all around the globe. Despite being a relatively young company, Intendis already has many years of experience in the research and development of top-quality dermatologicals, offering a broad spectrum of proven, outstanding products to treat acne, rosacea, eczema, psoriasis and fungal infections.
Key Facts
| Headquarters | Berlin, Germany |
| Staff (2007) | 900+ |
| Sales (2007) | 244 € Mill. |
| Shareholder | Bayer Schering Pharma AG |
| Countries | Austria, Brazil, France, Germany, Italy, Japan, Mexico, Poland, Portugal, Russia, Spain, Turkey, USA |
Intendis Management Structure
| President and CEO | Marc Lafeuille |
| Finance & Administration | Dr. Detlev Hessenbruch |
| Commercial Operations | Alok Kanti |
| Corporate Legal and Patents | Eva Gardyan - Eisenlohr |
| Global Development | Dr. Eugene O'Keefe |
| Business Development | Dr. Lilian Vakalopoulou |
| Manufacturing | Ernesto Oppici |
| Global Strategic Marketing | Anke Sandberg |
| Marketing & Sales US | Dr. Bernhard Schefter |
| Corporate Communications | Tobias Rockel |
